Product Information
VIOKACE 10,440-39,150 UNIT TAB is a brand product labeled by Aimmune Therapeutics, Inc., priced at $4.1506 per EA under NDC 73562010410. Its NADAC has been published 102 times since Oct 23, 2024.
Strength
39150; 10440; 39150 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Aimmune Therapeutics, Inc.NDC
73562010410
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022542On Market Since
3/1/2021
Price Statistics
The NADAC for VIOKACE 10,440-39,150 UNIT TAB has been published 102 times since Oct 23, 2024, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1506 per EA |
|---|---|
| All-time high | $4.1629 (May 13, 2026) |
| All-time low | $4.0300 (Oct 23, 2024) |
| 52-week high | $4.1629 |
| 52-week low | $4.0411 |
| Median price | $4.0423 |
| Average price | $4.0811 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pancrelipase market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aimmune Therapeutics, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pancrelipase market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VIOKACE 10,440-39,150 UNIT TAB?
The current National Average Drug Acquisition Cost (NADAC) for VIOKACE 10,440-39,150 UNIT TAB, manufactured by Aimmune Therapeutics, Inc., is $4.1506 per EA (NDC 73562010410), effective Sep 30, 2026.
How has the price of VIOKACE 10,440-39,150 UNIT TAB changed over time?
Over the history we have for it, the NADAC for VIOKACE 10,440-39,150 UNIT TAB has risen 3.0%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for VIOKACE 10,440-39,150 UNIT TAB?
Since Oct 23, 2024, the NADAC for VIOKACE 10,440-39,150 UNIT TAB has ranged from a low of $4.0300 (Oct 23, 2024) to a high of $4.1629 (May 13, 2026), with a median of $4.0423 per EA.
Are there cheaper alternatives to VIOKACE 10,440-39,150 UNIT TAB?
No other NADAC-published product currently shares the active ingredient and strength of VIOKACE 10,440-39,150 UNIT TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIOKACE 10,440-39,150 UNIT TAB?
VIOKACE 10,440-39,150 UNIT TAB (NDC 73562010410) is labeled by Aimmune Therapeutics, Inc., and CMS classifies it as a brand product.